Table 2 Detection rates of CTCs in 84 blood samples from 48 epithelial cancer patients and in 30 samples from 22 melanoma patients.
Carcinoma | Number of blood samples | Number of patients | Positivity of blood samples | Positivity of patients* |
|---|---|---|---|---|
Gastric | 5 | 3 | 80% (4/5) | 67% (2/3) |
Colon | 25 | 11 | 44% (11/25) | 64% (7/11) |
Ovarian | 8 | 6 | 50% (4/8) | 50% (3/6) |
Breast | 21 | 10 | 52% (11/21) | 60% (6/10) |
Cervix | 11 | 7 | 64% (7/11) | 86% (6/7) |
NSCLC | 4 | 3 | 75% (3/4) | 100% (3/3) |
SCCHN | 10 | 8 | 70% (7/10) | 75% (6/8) |
Melanoma | 32 | 22 | 53% (17/32) | 64% (14/22) |